This company listing is no longer active
Taiwan Leader Biotech Past Earnings Performance
Past criteria checks 0/6
Key information
18.2%
Earnings growth rate
21.3%
EPS growth rate
Personal Products Industry Growth | 13.9% |
Revenue growth rate | -9.4% |
Return on equity | -12.6% |
Net Margin | -74.0% |
Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Taiwan Leader Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 22 | 40 | -30 | 29 | 12 |
31 Mar 22 | 41 | -29 | 30 | 12 |
31 Dec 21 | 42 | -29 | 30 | 12 |
30 Sep 21 | 39 | -31 | 30 | 13 |
30 Jun 21 | 37 | -33 | 31 | 13 |
31 Mar 21 | 32 | -43 | 33 | 15 |
31 Dec 20 | 28 | -52 | 36 | 18 |
30 Sep 20 | 29 | -56 | 39 | 20 |
30 Jun 20 | 30 | -60 | 42 | 23 |
31 Mar 20 | 31 | -56 | 40 | 23 |
31 Dec 19 | 31 | -51 | 39 | 23 |
30 Sep 19 | 29 | -71 | 56 | 26 |
30 Jun 19 | 27 | -90 | 73 | 28 |
31 Mar 19 | 51 | -84 | 76 | 34 |
31 Dec 18 | 74 | -78 | 78 | 39 |
30 Sep 18 | 77 | -64 | 65 | 38 |
30 Jun 18 | 79 | -51 | 52 | 36 |
31 Mar 18 | 55 | -64 | 55 | 33 |
31 Dec 17 | 30 | -77 | 59 | 31 |
30 Sep 17 | 38 | -77 | 58 | 38 |
30 Jun 17 | 45 | -77 | 58 | 46 |
31 Mar 17 | 44 | -78 | 55 | 48 |
31 Dec 16 | 42 | -78 | 52 | 51 |
30 Sep 16 | 31 | -88 | 50 | 55 |
30 Jun 16 | 20 | -98 | 48 | 60 |
31 Mar 16 | 19 | -92 | 48 | 55 |
Quality Earnings: 8490 is currently unprofitable.
Growing Profit Margin: 8490 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 8490 is unprofitable, but has reduced losses over the past 5 years at a rate of 18.2% per year.
Accelerating Growth: Unable to compare 8490's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 8490 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (-4.7%).
Return on Equity
High ROE: 8490 has a negative Return on Equity (-12.62%), as it is currently unprofitable.